[go: up one dir, main page]

GB0017139D0 - Human monoclonal antibodies - Google Patents

Human monoclonal antibodies

Info

Publication number
GB0017139D0
GB0017139D0 GB0017139A GB0017139A GB0017139D0 GB 0017139 D0 GB0017139 D0 GB 0017139D0 GB 0017139 A GB0017139 A GB 0017139A GB 0017139 A GB0017139 A GB 0017139A GB 0017139 D0 GB0017139 D0 GB 0017139D0
Authority
GB
United Kingdom
Prior art keywords
monoclonal antibodies
human monoclonal
human
antibodies
monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0017139A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cenfold Holdings SA
Original Assignee
Cenfold Holdings SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cenfold Holdings SA filed Critical Cenfold Holdings SA
Priority to GB0017139A priority Critical patent/GB0017139D0/en
Publication of GB0017139D0 publication Critical patent/GB0017139D0/en
Priority to AU6930001A priority patent/AU6930001A/en
Priority to AU2001269300A priority patent/AU2001269300B2/en
Priority to PCT/GB2001/003059 priority patent/WO2002004607A1/en
Priority to IL15364101A priority patent/IL153641A0/en
Priority to AT01947654T priority patent/ATE440945T1/en
Priority to DE60139694T priority patent/DE60139694D1/en
Priority to CNB018150543A priority patent/CN100497601C/en
Priority to EP01947654A priority patent/EP1299524B1/en
Priority to JP2002509461A priority patent/JP2004502454A/en
Priority to CA002415484A priority patent/CA2415484A1/en
Priority to KR10-2003-7000213A priority patent/KR20030022850A/en
Priority to US10/336,424 priority patent/US7387873B2/en
Priority to NO20030019A priority patent/NO20030019L/en
Ceased legal-status Critical Current

Links

GB0017139A 2000-07-07 2000-07-12 Human monoclonal antibodies Ceased GB0017139D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GB0017139A GB0017139D0 (en) 2000-07-12 2000-07-12 Human monoclonal antibodies
KR10-2003-7000213A KR20030022850A (en) 2000-07-07 2001-07-09 Human myeloma cell line
DE60139694T DE60139694D1 (en) 2000-07-07 2001-07-09 HUMAN MYELOMA CELL LINE
EP01947654A EP1299524B1 (en) 2000-07-07 2001-07-09 Human myeloma cell line
PCT/GB2001/003059 WO2002004607A1 (en) 2000-07-07 2001-07-09 Human myeloma cell line
IL15364101A IL153641A0 (en) 2000-07-07 2001-07-09 Human myeloma cell line
AT01947654T ATE440945T1 (en) 2000-07-07 2001-07-09 HUMAN MYELOMA CELL LINE
AU6930001A AU6930001A (en) 2000-07-07 2001-07-09 Human myeloma cell line
CNB018150543A CN100497601C (en) 2000-07-07 2001-07-09 Human myeloma cell line
AU2001269300A AU2001269300B2 (en) 2000-07-07 2001-07-09 Human myeloma cell line
JP2002509461A JP2004502454A (en) 2000-07-07 2001-07-09 Human myeloma cell line
CA002415484A CA2415484A1 (en) 2000-07-07 2001-07-09 Human myeloma cell line
NO20030019A NO20030019L (en) 2000-07-07 2003-01-03 Human Myeloma cell line
US10/336,424 US7387873B2 (en) 2000-07-07 2003-01-03 Human myeloma cell line

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0017139A GB0017139D0 (en) 2000-07-12 2000-07-12 Human monoclonal antibodies

Publications (1)

Publication Number Publication Date
GB0017139D0 true GB0017139D0 (en) 2000-08-30

Family

ID=9895540

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0017139A Ceased GB0017139D0 (en) 2000-07-07 2000-07-12 Human monoclonal antibodies

Country Status (1)

Country Link
GB (1) GB0017139D0 (en)

Similar Documents

Publication Publication Date Title
IL156030A0 (en) Humanized antibodies
AU1174702A (en) Humanized anti-lt-beta-r antibodies
EP1432444A4 (en) Anti-a-beta antibodies
MXPA03001590A (en) ANTIBODIES TO HUMAN IL-1bgr;.
IL166244A0 (en) Super humanized antibodies
GB0029360D0 (en) Humanised antibodies and uses thereof
HUP0300841A3 (en) Agonist anti-trk-c monoclonal antibodies
AU1462300A (en) Human pan-hcv human monoclonal antibodies
IL198420A0 (en) Therapeutic human anti-il-1r1 monoclonal antibody
GB9911569D0 (en) Antibodies
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
AU2002365649A8 (en) Anti-dota antibody
EP1178829A4 (en) Human monoclonal antibody
GB0126378D0 (en) Antigen
GB0016824D0 (en) Human monoclonal antibodies
GB0017139D0 (en) Human monoclonal antibodies
EP1446416A4 (en) Tumor specific monoclonal antibodies
AR028262A1 (en) HUMAN FAP-ALFA SPECIFIC ANTIBODIES
GB0003359D0 (en) Monoclonal antibodies
GB0008160D0 (en) Monoclonal antibodies
GB0030139D0 (en) Monoclonal antibody
GB0029846D0 (en) Monoclonal antibody
GB0020794D0 (en) Humanised antibodies
GB0024673D0 (en) Therapeutic antibodies
GB0121727D0 (en) Monoclonal antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)